Learn how trial design can improve drug safety in our upcoming webinar
FDA explores topics like treatment discontinuation and estimating risk
FDA explores topics like treatment discontinuation and estimating risk
Report outlines achievements and activities in science and innovation
First treatment for patients aged 12 and older
Milestone marks growth of biosimilars in the U.S.
Uncomplicated UTIs are a frequent reason for antibiotic use in women
New center will support innovative approaches through collaboration
Learn how we use science and data to ensure drug safety, quality, and efficacy
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.